Non-rapid eye movement sleep activation occurs during NREM that is comparable to the type that occurs during REM. It is this sub-cortical activation that results in dreaming during the NREM stage during the morning hours. During non-REM sleep, the tonic drive to most respiratory muscles of the upper airway is inhibited. This has two consequences: However, because the diaphragm is largely driven by the autonomous system, it is relatively spared of non-REM inhibition. As such, the suction pressures it generates stay the same. This narrows the upper airway during sleep, increasing resistance and making airflow through the upper airway turbulent and noisy. For example,
REM rebound (SSRIs), such as citalopram and paroxetine, are potent inhibitors of REM sleep and may also cause a REM rebound on discontinuation. REM rebound REM rebound is the lengthening and increasing frequency and depth of rapid eye movement (REM) sleep which occurs after periods of sleep deprivation. When people have been prevented from experiencing REM, they take less time than usual to attain the REM state. When people are unable to obtain an adequate amount of REM sleep, the pressure to obtain REM sleep builds up. When the subject is able to sleep, they will spend a higher percentage of the